Form 8-K - Current report:
SEC Accession No. 0001558370-22-014321
Filing Date
2022-09-12
Accepted
2022-09-12 09:36:22
Documents
14
Period of Report
2022-09-12
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20220912x8k.htm   iXBRL 8-K 43148
2 EX-3.1 nrbo-20220912xex3d1.htm EX-3.1 13687
3 EX-99.1 nrbo-20220912xex99d1.htm EX-99.1 5550
  Complete submission text file 0001558370-22-014321.txt   192856

Data Files

Seq Description Document Type Size
4 EX-101.SCH nrbo-20220912.xsd EX-101.SCH 3155
5 EX-101.LAB nrbo-20220912_lab.xml EX-101.LAB 16588
6 EX-101.PRE nrbo-20220912_pre.xml EX-101.PRE 10539
8 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20220912x8k_htm.xml XML 5068
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 221237788
SIC: 2834 Pharmaceutical Preparations